Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Connetics receives milestone payment from Suntory

May 19, 1999

Enbrel shows positive results in early, active RA

May 18, 1999

Disappointing results from interim analysis of experimental lupus drug

May 18, 1999

Cytokine-suppressive antiinflammatory agents in development at SmithKline Beecham

May 18, 1999

Antiinflammatory and analgesic pyrazoles described by Fujisawa

May 14, 1999

Roche team synthesizes new series of PLA2 inhibitors

May 14, 1999

Enbrel warning related to infections issued by FDA and Immunex

May 13, 1999

Second COX-2 inhibitor reaches the market

May 13, 1999

Antagonists of MIP-1alpha/RANTES receptor disclosed by Takeda

May 12, 1999

Searle reports new COX-2 inhibitor series bearing a sulfonamide moiety

May 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...